oxaprozin has been researched along with Extravascular Hemolysis in 2 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We also found that the turbidimetric assay was free from interference at least up to 1200 mg/dL of hemolysis, 30 mg/dL of free bilirubin, 34." | 3.73 | Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue. ( Dasgupta, A; Datta, P; Scurlock, D, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datta, P | 1 |
| Scurlock, D | 1 |
| Dasgupta, A | 1 |
| Higuchi, S | 1 |
| Osada, Y | 1 |
| Shioiri, Y | 1 |
| Nakaike, S | 1 |
| Muramatsu, M | 1 |
| Tanaka, M | 1 |
| Arai, I | 1 |
| Amanuma, F | 1 |
| Otomo, S | 1 |
| Aihara, H | 1 |
2 other studies available for oxaprozin and Extravascular Hemolysis
| Article | Year |
|---|---|
Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue.
Topics: Bilirubin; Cross Reactions; Fluorescence Polarization Immunoassay; Hemolysis; Humans; Nephelometry a | 2005 |
[Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, oxaprozin, in experimental models].
Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Cyclooxygenase Inhibitors; Disease Models | 1984 |